SCCA Proton Therapy
Since proton therapy was approved by the U.S. Food and Drug Administration to treat patients in 1988, the medical community has continued to conduct research on the use of protons in treating different types of cancer through clinical trials. Over the years, many patients have volunteered to take part in these clinical trials to help find improvements in fighting cancer with proton therapy. In our quest to look for ways to improve the lives of patients with cancer, SCCA will participate in clinical trials to further our knowledge of the benefits of proton therapy in many tumor types.
Check back here as more clinical trials aimed at evaluating proton therapy for different types of cancer are expected to open soon.
Registry Study for Proton Therapy Outcomes
Evaluation Tracking Project: A Prospective Chart Review of Patients Treated With Proton Therapy
Investigator: George Laramore, MD; Conditions: Solid Tumors; Status: Recruiting; Study ID: NCT01255748
Pulmonary Functional Imaging for Radiation Treatment Planning for Lung Cancer
Investigator: Jing Zeng; Conditions: Lung Cancer; Status: Recruiting; Study ID: NCT01982123